MedTrace Logo

Antiplatelet Strategy for CCS Patients Undergoing CABG

NCT06881901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29898

Last updated 2025-03-18

No results posted yet for this study

Summary

To evaluate the long-term outcomes of different antiplatelet strategies, including DAPT, aspirin monotherapy, and clopidogrel monotherapy, in CCS patients undergoing CABG. A retrospective, population-based cohort study was conducted using data from the Korean National Health Insurance Service (K-NHIS) database.

Conditions

  • Chronic Coronary Syndrome
  • Coronary Artery Bypass Graft CABG

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06881901 on ClinicalTrials.gov